1. A possible role of BDNF in prostate cancer detection.
- Author
-
Bronzetti E, Artico M, Forte F, Pagliarella G, Felici LM, D'Ambrosio A, Vespasiani G, and Bronzetti B
- Subjects
- Aged, Brain-Derived Neurotrophic Factor physiology, Humans, Immunohistochemistry, Male, Middle Aged, Neurotrophin 3 analysis, Prostatic Neoplasms chemistry, Receptor, Nerve Growth Factor analysis, Receptor, trkA analysis, Receptor, trkB analysis, Brain-Derived Neurotrophic Factor analysis, Prostatic Neoplasms diagnosis
- Abstract
Many studies have demonstrated that both normal and malignant prostate cells respond to a variety of growth factors, while several significant differences were found between normal and tumoural cells. The aim of this study was to focus on the localization and distribution of the immuno-reactivity for neurotrophins (NTs) and neurotrophin receptors (NTRs) in normal, hyperplastic and prostate cancer cells, obtained from 40 subjects. We studied samples obtained from 16 prostate cancer (PC, retropubic radical prostatectomy), 20 benign prostatic hyperplasia (BPH, supra-pubic prostatectomy) and normal peripheral prostate tissue from four fresh male cadavers. Samples were examined via immunohistochemical techniques in order to detect the expression of nerve growth factor (NGF), brain derived neurotrophic factor (BDNF), neurotrophin 3 (NT3) and their own receptors TrkA, p75, TrkB and TrkC. We observed a high expression of BDNF and TrkB in PC and BPH, though no immuno-reactivity was found for p75. Low expression was reported by other NTs and NTRs in the normal peripheral prostate zone, BPH and PC. These data suggest a possible predictive role for NTs and NTRs, especially for BDNF and TrkB, in the diagnosis and/or management of prostate cancer. The absence of p75 expression confirms its supposed role in apoptotic phenomenon.
- Published
- 2008
- Full Text
- View/download PDF